97
Participants
Start Date
January 31, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
September 30, 2012
No drug will be used
Biomarker
No drug will be used
Biomarker
Research Site, Denver
Research Site, Normal
Research Site, Baltimore
Research Site, Ann Arbor
Research site, Rochester
Research Site, St Louis
Research Site, Chapel Hill
Research Site, Columbus
Research Site, Pittsburgh
Research Site, Galveston
Research Site, Houston
Research Site, Madison
Research Site, Calgary
Research Site, Edmonton
Research Site, Vancouver
Research Site, Toronto
Research Site, Montreal
Research Site, Québec
Lead Sponsor
MedImmune LLC
INDUSTRY